| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |